COVID-19 ResponseNCPIC adheres to all COVID related CDC guildlines and safety measures. All staff are fully vaccinated.
Positron Emission Tomography and Computed Tomography(PET/CT) imaging is one of the most rapidly growing technologies in Radiology.
In Oncology, PET/CT imaging can be used to help physicians detect cancers in their earliest stages, determine the full extent of malignant disease, assess the effectiveness of chemotherapy and recognize tumor recurrence.
In Neurology, PET/CT imaging provides the physician with information for assessing various neurological diseases such as Alzheimer’s disease and other dementia, Parkinson’s disease and Huntington’s disease. Additionally, PET/CT allows physicians to localize epilectic foci for qualifying and identifying the site requiring surgical intervention.
In Urology, PET/CT imaging enables physicians to detect prostate cancer recurrence, with patients that have had a prostatectomy and a rising PSA. With a bone scan, an excessive PSA level of 10 -30 ng/mL is needed to visualize anything. With new PET/CT imaging capabilities, we can now detect recurrent disease at levels less than 10 ng/mL.